NEW YORK (GenomeWeb News) — Baylor College of Medicine has licensed a number of patents from Affymetrix to perform certain microarray services in Clinical Laboratory Improvement Amendments environments, the groups said today.
Under the terms of the deal, scientists at Baylor’s Department of Molecular and Human Genetics will have non-exclusive rights to use Affy’s patents for comparative genomics hybridization microarray services.
Arthur Beaudet, chair of Baylor’s DMHG, said the scientists will use the technology “to identify specific genetic abnormalities in many children that have developmental disabilities with previously unknown causes.”
The DMHG conducts research in a wide variety of fields, including functional genomics, sequencing, human and mammal genome studies and numerous diseases.
Financial details or the duration of the agreement were not disclosed.